Market for chondroitin sulfate

From the overall point of view, the market space of chondroitin sulfate powder raw material industry is not large, low added value, many production enterprises, it is difficult to form large enterprises, and the investment value is small. Downstream health products and drugs have a certain industry scale, but product homogeneity is more serious, competition is fierce, and there are not many opportunities to grow bigger and stronger. At present, there are 4 companies in A-shares and the third Board with related businesses, and the sulfuric acid cartilage business is not the main business when Dongcheng Pharmaceutical and Tomson Bihealth are listed. The three board two companies, Haiyu Biological and Huiwen biological chondroitin sulfate business scale is small. In addition to Haiyu Biology, the chondroitin sulfate business revenue of other companies accounted for a small proportion of total revenue.